A high level of SMYD2 in CESC (HR 2.3, p = 0.00045) and a lower level of SMYD2 in KIRC (HR 0.49, p = 6E-06) were significantly correlated with the OS of cancer patients (Fig. 4). Here, SMYD2 is linked to cancer.